Learning from One of the World’s Leading Biobanks
On 8 December 2025, representatives of the InnoThyroGen project attended the UK Biobank Scientific Conference 2025 in London.
Dr. Nikolina Pleić and Dr. Andrea Gelemanović participated in the event to gain direct insight into one of the most advanced biobank systems in the world.
The conference brought together researchers, clinicians, data scientists and biobank experts.
Moreover, it provided a valuable platform for understanding how large-scale population cohorts are designed, managed and used in modern biomedical research.
Key Insights from the UK Biobank: InnoThyroGen at the UK Biobank Scientific Conference 2025
During the conference, special attention was given to the organisation and structure of the UK Biobank.
Participants explored how biological samples and data are collected, stored and harmonised across different research domains.
In addition, sessions focused on data access procedures and governance models.
These elements are crucial for ensuring both scientific usability and ethical compliance.
Furthermore, the integration of clinical, genomic and population-level data was presented as a key strength of the UK Biobank system.
As a result, the InnoThyroGen team gained practical knowledge directly applicable to their own biobank development.
From Knowledge to Practice: Strengthening the InnoThyroGen Biobank
The experience from London will now support the next phase of the InnoThyroGen biobank.
Firstly, the project will use these insights to optimise its biobank structure and organisation.
Secondly, improvements will be made in data governance and analytical workflows.
Moreover, aligning with UK Biobank best practices will help ensure compatibility with international standards.
This is particularly important for enabling collaboration and data sharing with other large-scale cohorts.
Impact of InnoThyroGen at the UK Biobank Scientific Conference 2025
Participation in the conference delivered several concrete outcomes:
- Improved understanding of large-scale biobank management
- Enhanced knowledge of data harmonisation and integration
- Stronger alignment with international biobanking standards
- Better preparation for long-term sustainability of the InnoThyroGen biobank
- Opportunities to use UK Biobank resources for complementary analyses
Consequently, InnoThyroGen at the UK Biobank Scientific Conference 2025 will contribute to higher-quality research outputs and more robust data infrastructure.
Expanding Scientific Potential Through Collaboration
In addition to organisational insights, the conference opened new perspectives for scientific collaboration.
Access to UK Biobank data can support comparative analyses and strengthen research findings.
Furthermore, it enables the project to position itself within a broader European and global research ecosystem.
This approach supports translational research and helps bridge the gap between data and clinical application.
Conclusion
The UK Biobank Scientific Conference 2025 offered valuable insight into the future of biomedical research and data-driven healthcare.
By learning from established best practices, the InnoThyroGen team is better equipped to build a strong, sustainable and internationally aligned biobank.
Therefore, InnoThyroGen at the UK Biobank Scientific Conference 2025 represents an important step in advancing the project’s scientific and infrastructural capacity.
Stay Connected
Stay tuned for more updates as the project continues to grow and evolve.
Follow InnoThyroGen on LinkedIn, X, Facebook and Instagram for the latest developments and research activities.
